©2019 Gilead Sciences, Inc. All rights reserved. UNBP4517 07/19
Identify patients who need treatment, then connect them to cure. Scientific advances have led to all-oral, fixed-dose regimens, which are shorter in duration and more effective than before.1,2,a
aCure, or sustained virologic response (SVR12), is defined as undetectable levels of HCV in the blood at 12 weeks after completion of therapy.1,3
Most recommended treatments are 12 weeks or less1
HIGH CURE RATES WITH INTERFERON-FREE OPTIONS2
bFor the most common genotype (genotype 1) in the United States.
Cure (SVR) has been shown to be durable.
>99% OF PATIENTS WHO REACHED SVR HAD UNDETECTABLE LEVELS OF HEP C RNA UP TO 5 YEARS OR MORE AFTER CESSATION OF TREATMENT.1,c
cStudies utilized interferon-based therapies and SVR24, the standard protocol before 2013 for measuring attainment of SVR.5